Australian Clinical Labs Limited

ASX:ACL.AX

3.54 (AUD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 9.4919.4914.9522.47610.485.2425.42112.71148.0324.015130.21465.1073.31.6557.07328.53744.45520.678-3.2-0.05
Depreciation & Amortization 32.36332.36363.70131.85161.89930.9560.85630.42857.83628.91848.2624.1345.40222.70142.6521.32540.151037.7510
Deferred Income Tax 0000-130.484000-102.89800000000000
Stock Based Compensation 1.5321.532000.9420.942000.7290.729001.0831.083000.1620.16200
Change In Working Capital -5.582-5.582005.7445.74400-13.503-13.503003.9153.915000000
Accounts Receivables -3.862-3.862008.7028.70200-14.06-14.06001.3751.375000000
Change In Inventory -0.867-0.867002.4982.49800-1.949-1.94900-1.131-1.131000000
Change In Accounts Payables 00000000000000000000
Other Working Capital -0.853-0.85300-5.456-5.456002.5062.506003.6713.671000000
Other Non Cash Items 5.2265.226132.2812.44131.83-2.6798.705-11.504111.51410.695100.4251.95387.863-6.46893.684.1954.711-20.83983.6720.05
Operating Cash Flow 43.0343.0373.53236.76680.41140.20663.2731.635101.70850.854182.37991.1945.76122.881108.10354.05259.015042.7210
Investing Activities:
Investments In Property Plant And Equipment -1.341-1.341-3.823-1.912-3.3-1.65-3.634-1.817-13.088-6.544-8.164-4.082-5.856-2.928-3.65-1.825-3.3780-6.0030
Acquisitions Net -0.272-0.272-0.258-0.262-5.23-2.688-0.018-0.0559.5064.675-60.297-30.2072.3081.1260.05600.04800.0620
Purchases Of Investments 0000000000000.0170-0.0170-0.4960-0.1910
Sales Maturities Of Investments 0000000000001.0660000000
Other Investing Activites 3.5223.522-6.983-3.3590.0730.0730.0460.0460.0780.0780.0590.0590.570.570.020.020000
Investing Cash Flow 1.9091.909-11.064-5.532-8.53-4.265-3.652-1.826-3.582-1.791-68.461-34.231-2.465-1.233-3.611-1.806-3.8260-6.1320
Financing Activities:
Debt Repayment 00000000-450-55000000000
Common Stock Issued 000000004.9440-4.9440146.25300.00100000
Common Stock Repurchased -0.871-0.8710000-0.891-0.446-4.9440-2.472-2.472-38.3360-36.79800000
Dividends Paid -2.911-2.911-14.128-7.064-14.153-7.077-82.727-41.364-24.218-12.10900-21-10.5-21-10.50000
Other Financing Activities -40.552-40.552-14.608-21.672-19.844-26.9213.296.868-49.848-47.4249.022-48.4520.478-11.023-83.325-41.663-32.350-28.5660
Financing Cash Flow -44.334-44.334-57.472-28.736-67.993-33.997-69.883-34.942-119.066-59.533-101.844-50.922-43.045-21.523-104.325-52.163-32.350-28.5660
Other Information:
Effect Of Forex Changes On Cash -0.006-0.006-0.007-0.007-0.033-0.0330.0130.013-0.007-0.0070.010.01-0.002-0.002-0.015-0.0150000
Net Change In Cash 1.1980.5994.9832.4923.8231.912-10.24-5.12-20.954-10.47712.0936.0470.2470.1240.1370.06922.83908.0230
Cash At End Of Period 26.1360.59924.9382.49219.95518.04416.132-5.1226.37236.84947.3266.04735.23335.1134.9860.06934.84908.0230